Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Current Assets (2020 - 2025)

Rapid Micro Biosystems' Current Assets history spans 6 years, with the latest figure at $61.2 million for Q4 2025.

  • On a quarterly basis, Current Assets fell 24.41% to $61.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $61.2 million, a 24.41% decrease, with the full-year FY2025 number at $61.2 million, down 24.41% from a year prior.
  • Current Assets hit $61.2 million in Q4 2025 for Rapid Micro Biosystems, down from $70.0 million in the prior quarter.
  • Over the last five years, Current Assets for RPID hit a ceiling of $244.2 million in Q3 2021 and a floor of $60.1 million in Q2 2025.
  • Historically, Current Assets has averaged $123.9 million across 5 years, with a median of $118.0 million in 2021.
  • Biggest five-year swings in Current Assets: soared 250.96% in 2021 and later tumbled 40.79% in 2022.
  • Tracing RPID's Current Assets over 5 years: stood at $218.1 million in 2021, then tumbled by 36.47% to $138.6 million in 2022, then decreased by 13.11% to $120.4 million in 2023, then tumbled by 32.8% to $80.9 million in 2024, then decreased by 24.41% to $61.2 million in 2025.
  • Business Quant data shows Current Assets for RPID at $61.2 million in Q4 2025, $70.0 million in Q3 2025, and $60.1 million in Q2 2025.